News for Eiger BioPharmaceuticals, Inc. (EIGR)

**media[504207,504208]**

Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer

BERKELEY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. ( CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical compan

Amylyx faces challenges after a failed drug, but management is optimistic with a strong balance sheet and new opportunities for investors. Read more here.

Eiger BioPharmaceuticals plans equity cancellation under Chapter 11

Data from Amylyx Pharmaceuticals, Inc.'s phase 2 HELIOS trial, using AMX0035 to treat patients with Wolfram syndrome, expected Fall of 2024. Click for more on AMLX stock here.

Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.60%

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.

Eiger Biopharmaceuticals (EIGR) stock drops 52% as the company reportedly files for Chapter 11 bankruptcy in the wake of a 1-for-30 reverse stock split. Read more here.

Clinical trial data demonstrated Zokinvy treatment extended life by an average of 4.3 years in children and young adults with Hutchinson-Gilford progeriaEiger to receive $500,000 approval milestone...

Eiger BioPharmaceuticals, Inc. announced that it and its partner AnGes, Inc. received marketing approval from the Ministry of Health, Labour and Welfare for Zokinvy , a treatment for...

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 150 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.43% to 35,239.40 while the NASDAQ rose 1% to 14,342.66. The S&P 500 also rose, gaining, 0.63% to 4,566.74.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.20%

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.55%

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%, and the S&P 500 down around 3.3%.

/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...